Ann: FDA Grants Orphan Drug Designation for Revascor, page-143

"The only reason I come around here a bit smug..."

Let me help you with that.

"Though TBH it was a very minor investment, something I wasn't upset to lose."

This took me all of five minutes to dig this up, and plenty more where that came from (buying with ears pinned back etc., buying at various price points as the share price tanked - you name it): https://hotcopper.com.au/threads/general-chat.5048807/page-895?post_id=51804041. Flooding the zone isn't really an effective strategy with an advanced search feature. This stuff is super easy to pull up.

"Wouldn't have minded someone coming around there warning me about management."

Just the management? You were completely blindsided by the need for basic clinical studies to support any real uptake/marketing applications for Felix.....all the while reinforcing the idea to other MEM holders that the company could get any serious traction without them - via some basic initial KOL interest. In essence, you pretty much bought everything that MEM management was selling - and yet you now expect holders and prospective holders of MSB alike to consider your take on MSB management and its strategies for their products?

I would say tread carefully prospective holders of MSB, particularly where you observe a non-holding poster who's financial interest and motives are unclear. Be sure to check their posting history and try to get a read on their expertise and their commentary on other companies, otherwise you may risk attributing more weight to an opinion than is warranted, or you may fall prey to a cognitive bias, e.g. like seeing "Doc" in someones name and assuming they must be somehow qualified to comment (authority bias) - beware.

(Nothing like a bit of mind-bending hypocrisy right? )